Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05608-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Qun Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, RNA, Long Noncoding, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningbo special support program for high-level personnel recruitment.
Abstract (Originalsprache)
Background
Long noncoding RNAs (lncRNAs) are implicated in the tumor immunology of hepatocellular carcinoma (HCC).
Methods
HCC mRNA and lncRNA expression profiles were used to extract immune-related genes with the ImmPort database, and immune-related lncRNAs with the ImmLnc algorithm. The MOVICS package was used to cluster immune-related mRNA, immune-related lncRNA, gene mutation and methylation data on HCC from the TCGA. GEO and ICGC datasets were used to validate the model. Data from single-cell sequencing was used to determine the expression of genes from the model in various immune cell types.
Results
With this model, the area under the curve (AUC) for 1-, 3- and 5-year survival of HCC patients was 0.862, 0.869 and 0.912, respectively. Single-cell sequencing showed EREG was significantly expressed in a variety of immune cell types. Knockdown of the EREG target gene resulted in significant anti-apoptosis, pro-proliferation and pro-migration effects in HepG2 and HUH7 cells. Moreover, serum and liver tissue EREG levels in HCC patients were significantly higher than those of healthy control patients.
Conclusion
We built a prognostic model with good accuracy for predicting HCC patient survival. EREG is a potential immunotherapeutic target and a promising prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 Jiangnan Rd., Ningbo, 315100, China. quncai@zju.edu.cn.
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150036, Heilongjiang, China.
- Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 Jiangnan Rd., Ningbo, 315100, China.
Förderung
- Ningbo special support program for high-level personnel recruitment
Zitieren
APA
Cai, Q., Li, G., Zhu, M., Zhuo, T., & Xiao, J. (2024). Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05608-6
Vancouver
Cai Q, Li G, Zhu M, Zhuo T, Xiao J. Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05608-6
BibTeX
@article{Cai2024,
author = {Cai, Qun and Li, Guoqi and Zhu, Mingyan and Zhuo, Tingting and Xiao, Jiaying},
title = {Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05608-6}
}
EUVIMED